Three-dimensional Scaffold Containing EGF Incorporated Biodegradable Polymeric Nanoparticles for Stem Cell Based Tissue Engineering Applications

被引:6
作者
Pulavendran, Sivasami [1 ]
Thiyagarajan, Gurunathen [1 ]
机构
[1] Cent Leather Res Inst Adyar, Dept Biotechnol, Madras 600020, Tamil Nadu, India
关键词
collagen; chitosan; epidermal growth factor; nanoparticles; mesenchymal stem cells; tissue engineering; EPIDERMAL-GROWTH-FACTOR; BONE-MARROW; DIFFERENTIATION; DELIVERY; MATRICES; COLLAGEN; PROTEIN; DNA;
D O I
10.1007/s12257-009-3155-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Stem cell-based tissue engineering holds much hope for the development of multifunctional tissues to replace diseased organs. The attachment and survival of stem cells on a three-dimensional (3D) scaffold must be enhanced for faster progression of stem cell based tissue engineering. This study evaluate the stability of mesenchymal stem cells (MSCs) in 3D porous scaffolds composed of a collagen and chitosan blend impregnated with epidermal growth factor incorporated chitosan nanoparticles (EGF-CNP). The EGF-CNP scaffolds were characterized by transmission electron microscopy, which revealed that the nanoparticles were round in shape and 20 similar to 50 tun in size. The scaffolds were prepared by freeze drying. A Fourier-transform infrared spectrum study revealed that the linkage between collagen and chitosan was through an ionic interaction. Thermal analysis and degradation studies showed that the scaffold could be used in tissue engineering application. MSCs proliferated well in the EGF-CNP impregnated scaffold. A scanning electron microscope study showed anchored and elongated MSCs on the EGF-CNP impregnated scaffold. A 3D biodegradable collagen chitosan scaffold impregnated with EGF-CNP is a promising transportable candidate for MSC-based tissue engineering, and this scaffold could be used as an in vitro model for subsequent clinical applications.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 24 条
[1]  
Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO
[2]  
2-A
[3]  
Bhattacharya S, 2007, FASEB J, V21, pA1315
[4]   Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles [J].
Cetin, Meltem ;
Aktas, Yesim ;
Vural, Imran ;
Capan, Yilmaz ;
Dogan, Lale A. ;
Duman, Memed ;
Dalkara, Turgay .
DRUG DELIVERY, 2007, 14 (08) :525-529
[5]   Mesenchymal Stem Cell Concentration and Bone Repair: Potential Pitfalls from Bench to Bedside [J].
Cuomo, Anna V. ;
Virk, Mandeep ;
Petrigliano, Frank ;
Morgan, Elise F. ;
Lieberman, Jay R. .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (05) :1073-1083
[6]   Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells [J].
Fan, Vivian H. ;
Au, Ada ;
Tamama, Kenichi ;
Littrell, Romie ;
Richardson, Llewellyn B. ;
Wright, John W. ;
Wells, Alan ;
Griffith, Linda G. .
STEM CELLS, 2007, 25 (05) :1241-1251
[7]   Controlled differentiation of stem cells [J].
Hwang, Nathaniel S. ;
Varghese, Shyni ;
Elisseeff, Jennifer .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (02) :199-214
[8]   Effects of three-dimensional culture and growth factors on the chondrogenic differentiation of murine embryonic stem cells [J].
Hwang, Nathaniel S. ;
Kim, Myoung Sook ;
Sampattavanich, Somponnat ;
Baek, Jin Hyen ;
Zhang, Zijun ;
Elisseeff, Jennifer .
STEM CELLS, 2006, 24 (02) :284-291
[9]   In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells [J].
Johnstone, B ;
Hering, TM ;
Caplan, AI ;
Goldberg, VM ;
Yoo, JU .
EXPERIMENTAL CELL RESEARCH, 1998, 238 (01) :265-272
[10]   Stem cell therapy for liver disease: Parameters governing the success of using bone marrow mesenchymal stem cells [J].
Kuo, Tom K. ;
Hung, Shun-Pei ;
Chuang, Chiao-Hui ;
Chen, Chien-Tsun ;
Shih, Yu-Ru V. ;
Fang, Szu-Ching Y. ;
Yang, Vincent W. ;
Lee, Oscar K. .
GASTROENTEROLOGY, 2008, 134 (07) :2111-2121